Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 866 entries
View as:

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03236857 Org: User:
Start: 11/08/17 End: 04/19/23 Due: 04/19/24

A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT05308654 Org: User:
Start: 05/17/22 End: 12/08/25 Due: 12/08/26

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05878067 Org: User:
Start: 06/27/23 End: 10/06/23 Due: 10/06/24

Expanded Access to Veliparib

Phase: N/A Priority: Normal
NCT ID: NCT03123211 Org: User:
Start: - End: - Due: -

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Phase: N/A Priority: Normal
NCT ID: NCT05210803 Org: User:
Start: 12/20/21 End: 03/31/28 Due: 03/31/29

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05496348 Org: User:
Start: 10/20/22 End: 08/31/27 Due: 08/31/28

Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

Phase: N/A Priority: Normal
NCT ID: NCT04166058 Org: User:
Start: 11/19/19 End: 06/05/25 Due: 06/05/26

A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03924947 Org: User:
Start: 10/23/19 End: 07/11/22 Due: 07/11/23

A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02009631 Org: User:
Start: 11/30/13 End: 12/31/14 Due: 12/31/15

A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT03886220 Org: User:
Start: 04/12/19 End: 04/28/21 Due: 04/28/22

Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])

Phase: N/A Priority: Normal
NCT ID: NCT02414633 Org: User:
Start: 04/01/15 End: 03/13/17 Due: 03/13/18

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02219503 Org: User:
Start: 09/30/14 End: 09/30/15 Due: 09/30/16

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02782663 Org: User:
Start: 05/18/16 End: 09/17/25 Due: 09/17/26

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02065622 Org: User:
Start: 03/27/14 End: 11/11/19 Due: 11/11/20

A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

Phase: N/A Priority: Normal
NCT ID: NCT03725202 Org: User:
Start: 02/06/19 End: 02/24/25 Due: 02/24/26

Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

Phase: N/A Priority: Normal
NCT ID: NCT02750800 Org: User:
Start: 04/07/16 End: 04/03/18 Due: 04/03/19

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03568318 Org: User:
Start: 08/09/18 End: 11/16/30 Due: 11/16/31

A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02513459 Org: User:
Start: 09/16/15 End: 06/19/19 Due: 06/19/20

A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT06100744 Org: User:
Start: 07/08/24 End: 10/31/28 Due: 10/31/29

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01853033 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib

Phase: N/A Priority: Normal
NCT ID: NCT04846244 Org: User:
Start: 04/30/21 End: 03/24/25 Due: 03/24/26

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05771428 Org: User:
Start: 04/27/23 End: 09/12/24 Due: 09/12/25

RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT02556736 Org: User:
Start: 12/14/15 End: 10/21/24 Due: 10/21/25

A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03695185 Org: User:
Start: 03/26/19 End: 01/10/22 Due: 01/10/23

A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05376839 Org: User:
Start: 07/06/22 End: 11/08/22 Due: 11/08/23